This topic contains a solution. Click here to go to the answer

Author Question: Why is the perspective of third-party payers and administrators an issue when costbenefit analysis ... (Read 79 times)

humphriesbr@me.com

  • Hero Member
  • *****
  • Posts: 550
Why is the perspective of third-party payers and administrators an issue when costbenefit analysis is performed?
 
  a. Administrators do not focus equally on costs and benefits.
  b. Administrators are not experts in costbenefit analyses.
  c. Administrators lack understanding of health care benefits used in such analyses.
  d. Administrators ignore the client perspective of time, energy, and money.

Question 2

Which of the following is one of the goals of Healthy People 2020?
 
  a. Decreasing institutionalizatio n and increasing community-based care services
  b. Achieving health equity, eliminating disparities, and improving the health of all groups
  c. Creating environments to improve the eating and exercise habits of all people
  d. Expanding the technology, resources, and medications used to treat chronic illness



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

sailorcrescent

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

ANS: D

Answer to Question 2

ANS: B




humphriesbr@me.com

  • Member
  • Posts: 550
Reply 2 on: Jul 8, 2018
Gracias!


mcarey591

  • Member
  • Posts: 365
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

The ratio of hydrogen atoms to oxygen in water (H2O) is 2:1.

Did you know?

After 5 years of being diagnosed with rheumatoid arthritis, one every three patients will no longer be able to work.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.

For a complete list of videos, visit our video library